Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -24.787.6324.25407.44261.92

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -24.78 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-24.78
Mar20237.63
Mar202224.25
Mar2021407.44
Mar2020261.92

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25
-94.05
Mar2021 407.44
55.56
Mar2020 261.92 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹384.0 Cr -1.9% -3.6% -20.8% Stock Analytics
ADANI ENTERPRISES ₹269,905.0 Cr 3.4% -1.5% -28.4% Stock Analytics
REDINGTON ₹18,117.6 Cr 13.8% 13.6% 17.9% Stock Analytics
MMTC ₹10,006.5 Cr 0.6% -5% -28.7% Stock Analytics
HONASA CONSUMER ₹6,959.4 Cr -4.6% -11.4% -48.8% Stock Analytics
MSTC ₹4,068.4 Cr -0.6% -8.4% -46.3% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-1.9%

-3.6%

-20.8%

SENSEX

0.5%

0.3%

7.9%


You may also like the below Video Courses